Wenqiang Chen

Weifang Medical University — China

Biochemistry, Genetics and Molecular Biology · Life Sciences

16h-index1.4kcitations83works1.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer-related molecular mechanisms research(10), MicroRNA in disease regulation(6), Hemoglobinopathies and Related Disorders(6), Erythrocyte Function and Pathophysiology(6), Cancer Immunotherapy and Biomarkers(5)

Publications83 total

1290 Comparison of gene expression profiles of gastric cancer tissues in Chinese and Korean patients based on bulk RNA sequencing data
Regular and Young Investigator Award Abstracts·2025Open Access
Inductive spatial temporal graph convolutional neural network for granary temperature field reconstruction
Journal of Stored Products Research·2025· 1 cited
Abstract B002: Effects of Proglumide with Chemotherapy on the Pancreatic Tumor Microenvironment: Phase 1 PROGEM Trial
Cancer Research·2025
Mechanistic Insights into Proglumide’s Role in Immune Cell Efficacy and Response to Immune Checkpoint Inhibitor Therapy in Hepatocellular Carcinoma
Cancers·2025· 1 citedOpen Access
Tu1413: DE NOVO EXPRESSION OF THE CHOLECYSTOKININ-B RECEPTOR INCREASES RISK OF ADM PROGRESSION IN CHRONIC PANCREATITIS
Gastroenterology·2025
Combining anti-PD-1 antibodies with surufatinib for gastrointestinal neuroendocrine carcinoma: Two cases report and review of literature
World Journal of Clinical Oncology·2025Open Access
Remodeling tumor microenvironment by versatile nanoplatform orchestrated mechanotherapy with chemoimmunotherapy to synergistically enhance anticancer efficiency
Biomaterials·2025· 6 cited
NARROW AND ROLLED LEAF 9, a Novel Gene Encoding 20S Proteasome β1 Subunit that Regulates Leaf Morphology and Grain Size in Rice
Rice Science·2024Open Access
Dopamine
Trends in Endocrinology and Metabolism·2024
Corrigendum to “Synergistically enhanced cancer immunotherapy by combining protamine-based nanovaccine with PD-L1 gene silence nanoparticle” [Int. J. Biol. Macromol. 242 (2023) 125223]
International Journal of Biological Macromolecules·2024
Independent association between prostate-specific antigen nadir and PSA progression-free survival in first-line abiraterone acetate treatment in castration-resistant prostate cancer patients: a pilot study
Frontiers in Oncology·2024· 1 citedOpen Access
Tu1418 TARGET-SPECIFIC LNA GAPMERS DECREASE GROWTH AND METASTASES OF PANCREATIC CANCER
Gastroenterology·2024
1151 ROLE OF A CCK RECEPTOR ANTAGONIST PROGLUMIDE IN MANAGEMENT OF CHRONIC PANCREATITIS - PHASE 1 STUDY
Gastroenterology·2024
The Role of a Cholecystokinin Receptor Antagonist in the Management of Chronic Pancreatitis: A Phase 1 Trial
Pharmaceutics·2024· 7 citedOpen Access
Knockdown of SETD5 Inhibits Colorectal Cancer Cell Growth and Stemness by Regulating PI3K/AKT/mTOR Pathway
Biochemical Genetics·2024· 1 cited
Abstract 3250: LNA gapmer to gastrin inhibits growth and metastases of human pancreatic cancer in mice
Cancer Research·2024
Loss of Insulin Signaling in Microglia Impairs Cellular Uptake of Aβ and Neuroinflammatory Response Exacerbating Alzheimer-Like Neuropathology
SSRN Electronic Journal·2024· 2 citedOpen Access
Feasibility of apalutamide combined with androgen deprivation therapy and short-course low-dose prednisone in treating metastatic hormone-sensitive prostate cancer: a pilot randomized controlled trial
Frontiers in Oncology·2023· 1 citedOpen Access
Synergistically enhanced cancer immunotherapy by combining protamine-based nanovaccine with PD-L1 gene silence nanoparticle
International Journal of Biological Macromolecules·2023· 7 cited
Precise diagnosis of lung cancer enabled by improved FTIR-based machine learning
Infrared Physics & Technology·2023· 14 cited
page 1 of 5Next →

Frequent Co-authors

Jill P. Smith(9), Hong Cao(6), Xiaobo Huang(5), Zengfu Deng(5), Lin Liao(5), Faquan Lin(5), Bhaskar Kallakury(5), Martha D. Gay(4), Narayan Shivapurkar(4), Xiuwen Guan(3), Yujing Chen(3), Ningqun Wang(3), Yifeng Tao(3), Yuling Qiu(3), Hongshuo Shi(3), Guomin Si(3), Kaihui Liu(2), Xiaowei Ding(2), Deng Bai-wan(2), Mingxia Jiang(2)